Meredith Hardt
Acute Care · Mesa, AZNPI 1073183240
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,556, more than ten times the $119 reported in 2021.
Across 155 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$456
- Johnson & Johnson$344
- QOL Medical, LLC$285
- Madrigal Pharmaceuticals$199
- Ipsen Biopharmaceuticals, Inc$195
- Ardelyx, Inc.$170
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,155100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $456 |
| Johnson & Johnson | 20 | $344 |
| QOL Medical, LLC | 8 | $285 |
| Madrigal Pharmaceuticals | 10 | $199 |
| Ipsen Biopharmaceuticals, Inc | 8 | $195 |
| Ardelyx, Inc. | 7 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $163 |
| Regeneron Healthcare Solutions, Inc. | 5 | $133 |
| AstraZeneca | 8 | $121 |
| Sanofi | 5 | $117 |
| Lilly USA, LLC | 6 | $108 |
| Bayer | 2 | $90 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $83 |
| Phathom Pharmaceuticals, Inc. | 3 | $78 |
| Akebia Therapeutics Inc | 3 | $61 |
| Aimmune Therapeutics, Inc. | 2 | $58 |
| Pfizer | 2 | $47 |
| Biocon Biologics Inc | 2 | $43 |
| Organon | 2 | $43 |
| Ferring Pharmaceuticals Inc. | 2 | $41 |
| Gilead | 2 | $35 |
| Celltrion USA Inc. | 2 | $34 |
| Braintree Laboratories, Inc. | 1 | $26 |
| Aurinia Pharma U.S., Inc. | 2 | $26 |
| Merck | 1 | $25 |
| Amgen | 1 | $24 |
| Orphalan Inc | 1 | $24 |
| Mauna Kea Technologies, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| Calliditas Therapeutics US Inc. | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Digestive Care, Inc. | 1 | $15 |
| Sirtex Medical Inc | 1 | $13 |
How this compares
$3,155 in reported general payments places this provider in the 80th percentile of 482 acute care providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 13 | $206 |
Paid to pharmacies, not to this prescriber.
Other acute care in Mesa
- Seania BristolMesa$11K
- Traci SchragMesa$7K
- Courtney BradfordMesa$5K
- Shannon JenningsMesa$5K
- Carmen LombardoMesa$4K
- Nicole CiffoneTucson$162K
- Kim KrmpoticPhoenix$79K
- Stephanie WilsonScottsdale$37K
- Laura Cook-GongoraPhoenix$32K
- Cathy PaynePhoenix$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.